- Home
- RVSN vs MBRX Comparison
RVSN vs MBRX Comparison
Compare RVSN & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSN
- MBRX
- Stock Information
- Founded
- RVSN 2016
- MBRX 2015
- Country
- RVSN Israel
- MBRX United States
- Employees
- RVSN N/A
- MBRX N/A
- Industry
- RVSN
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- RVSN
- MBRX Health Care
- Exchange
- RVSN Nasdaq
- MBRX Nasdaq
- Market Cap
- RVSN 8.6M
- MBRX 7.7M
- IPO Year
- RVSN 2022
- MBRX 2016
- Fundamental
- Price
- RVSN $0.48
- MBRX $2.70
- Analyst Decision
- RVSN
- MBRX Strong Buy
- Analyst Count
- RVSN 0
- MBRX 3
- Target Price
- RVSN N/A
- MBRX $31.00
- AVG Volume (30 Days)
- RVSN 381.1K
- MBRX 54.8K
- Earning Date
- RVSN 11-26-2024
- MBRX 11-08-2024
- Dividend Yield
- RVSN N/A
- MBRX N/A
- EPS Growth
- RVSN N/A
- MBRX N/A
- EPS
- RVSN N/A
- MBRX N/A
- Revenue
- RVSN $903,000.00
- MBRX N/A
- Revenue This Year
- RVSN $1,344.37
- MBRX N/A
- Revenue Next Year
- RVSN $1,143.30
- MBRX N/A
- P/E Ratio
- RVSN N/A
- MBRX N/A
- Revenue Growth
- RVSN 347.03
- MBRX N/A
- 52 Week Low
- RVSN $0.38
- MBRX $0.40
- 52 Week High
- RVSN $23.37
- MBRX $6.24
- Technical
- Relative Strength Index (RSI)
- RVSN 48.36
- MBRX 53.82
- Support Level
- RVSN $0.47
- MBRX $2.50
- Resistance Level
- RVSN $0.56
- MBRX $3.33
- Average True Range (ATR)
- RVSN 0.05
- MBRX 0.24
- MACD
- RVSN -0.00
- MBRX 0.04
- Stochastic Oscillator
- RVSN 37.11
- MBRX 39.42
About RVSN Rail Vision Ltd.
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.